Robert Gray Buys 3,500 Shares of enVVeno Medical Corporation (NASDAQ:NVNO) Stock

enVVeno Medical Corporation (NASDAQ:NVNO) Director Robert Gray acquired 3,500 shares of enVVeno Medical stock in a transaction that occurred on Tuesday, December 31st. The shares were purchased at an average price of $2.94 per share, for a total transaction of $10,290.00. Following the transaction, the director now directly owns 11,155 shares in the company, valued at $32,795.70. The trade was a 45.72 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink.

enVVeno Medical Trading Up 9.4 %

NASDAQ:NVNO opened at $3.36 on Friday. The stock’s 50-day moving average is $3.16 and its 200-day moving average is $4.24. enVVeno Medical Corporation has a 1-year low of $2.45 and a 1-year high of $6.97. The stock has a market cap of $58.93 million, a P/E ratio of -2.60 and a beta of 1.22.

enVVeno Medical (NASDAQ:NVNO) last posted its earnings results on Thursday, October 31st. The company reported ($0.35) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.33) by ($0.02). As a group, equities analysts forecast that enVVeno Medical Corporation will post -1.3 EPS for the current year.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. Hohimer Wealth Management LLC bought a new stake in shares of enVVeno Medical in the 3rd quarter valued at about $286,000. Maven Securities LTD bought a new stake in enVVeno Medical in the third quarter valued at approximately $295,000. Westside Investment Management Inc. increased its position in enVVeno Medical by 128.0% during the 3rd quarter. Westside Investment Management Inc. now owns 88,375 shares of the company’s stock valued at $297,000 after purchasing an additional 49,613 shares during the period. Corsair Capital Management L.P. bought a new position in enVVeno Medical during the 3rd quarter worth approximately $390,000. Finally, Geode Capital Management LLC lifted its position in shares of enVVeno Medical by 7.8% in the 3rd quarter. Geode Capital Management LLC now owns 150,676 shares of the company’s stock worth $506,000 after purchasing an additional 10,902 shares during the period. 34.71% of the stock is owned by institutional investors.

enVVeno Medical Company Profile

enVVeno Medical Corporation (Nasdaq: NVNO) is an medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. The company’s lead product, the VenoValve®️, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).